TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Low Glycemic Index Mediterranean Diet Effect on Moderate or Severe Non-alcoholic Fatty Liver Disease
Brief Summary: Non-alcoholic fatty liver disease (NAFLD) is a clinical/biochemical condition associated with the metabolic syndrome. As the disease stems from excess calorie intake and lack of physical activity, the correction of unhealthy lifestyles is the background of any prevention and treatment strategy


Options:
A: Arm Label: Glucose; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Glucose | Arm Label: Fructose; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Fructose | Intervention Type: DIETARY_SUPPLEMENT; Name: Glucose; Assigned to Arm(s): Glucose | Intervention Type: DIETARY_SUPPLEMENT; Name: Fructose; Assigned to Arm(s): Fructose
B: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: exercise | Intervention Type: BEHAVIORAL; Name: exercise; Assigned to Arm(s): Exercise
C: Arm Label: Diet: Dietary Advice; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: General Advice | Arm Label: Low glycemic index Mediterranean Diet; Type: EXPERIMENTAL; Interventions: Behavioral: Low Glycemic Index Mediterranean Diet | Intervention Type: BEHAVIORAL; Name: Low Glycemic Index Mediterranean Diet; Assigned to Arm(s): Low glycemic index Mediterranean Diet | Intervention Type: BEHAVIORAL; Name: General Advice; Assigned to Arm(s): Diet: Dietary Advice
D: Arm Label: Low glycemic index dietary intervention program; Type: ACTIVE_COMPARATOR; Interventions: Other: Low glycemic index dietary intervention program | Arm Label: Simple lifestyle advice; Type: PLACEBO_COMPARATOR; Interventions: Other: simple lifestyle advice | Intervention Type: OTHER; Name: Low glycemic index dietary intervention program; Assigned to Arm(s): Low glycemic index dietary intervention program | Intervention Type: OTHER; Name: simple lifestyle advice; Assigned to Arm(s): Simple lifestyle advice

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Low Glycemic Index Mediterranean Diet Effect on Moderate or Severe Non-alcoholic Fatty Liver Disease
Brief Summary: Non-alcoholic fatty liver disease (NAFLD) is a clinical/biochemical condition associated with the metabolic syndrome. As the disease stems from excess calorie intake and lack of physical activity, the correction of unhealthy lifestyles is the background of any prevention and treatment strategy


Options:
A: Arm Label: Intensive Portfolio; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Dietary Portfolio - Intensive | Arm Label: Routine Portfolio; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Dietary Portfolio - Routine | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Control (low saturated fat therapeutic diet) | Intervention Type: DIETARY_SUPPLEMENT; Name: Dietary Portfolio - Intensive; Assigned to Arm(s): Intensive Portfolio | Intervention Type: DIETARY_SUPPLEMENT; Name: Dietary Portfolio - Routine; Assigned to Arm(s): Routine Portfolio | Intervention Type: DIETARY_SUPPLEMENT; Name: Control (low saturated fat therapeutic diet); Assigned to Arm(s): Control
B: Arm Label: Diet: Dietary Advice; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: General Advice | Arm Label: Low glycemic index Mediterranean Diet; Type: EXPERIMENTAL; Interventions: Behavioral: Low Glycemic Index Mediterranean Diet | Intervention Type: BEHAVIORAL; Name: Low Glycemic Index Mediterranean Diet; Assigned to Arm(s): Low glycemic index Mediterranean Diet | Intervention Type: BEHAVIORAL; Name: General Advice; Assigned to Arm(s): Diet: Dietary Advice
C: Arm Label: Mediterranean Diet; Type: EXPERIMENTAL; Interventions: Other: mediterranean diet | Arm Label: normocaloric diet; Type: ACTIVE_COMPARATOR; Interventions: Other: normocaloric diet | Intervention Type: OTHER; Name: mediterranean diet; Assigned to Arm(s): Mediterranean Diet | Intervention Type: OTHER; Name: normocaloric diet; Assigned to Arm(s): normocaloric diet
D: Arm Label: Arm A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Written dietary recommendations | Arm Label: Arm B; Type: EXPERIMENTAL; Interventions: Behavioral: Cocinar Para Su Salud Program | Intervention Type: BEHAVIORAL; Name: Cocinar Para Su Salud Program; Assigned to Arm(s): Arm B | Intervention Type: BEHAVIORAL; Name: Written dietary recommendations; Assigned to Arm(s): Arm A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Different Therapies on Surrogate Markers of Cardiovascular Risk in Women With Polycystic Ovary Syndrome (PCOS)
Brief Summary: In addition to chronic anovulation and hyperandrogenemia, polycystic ovary syndrome (PCOS) is also characterized by peripheral insulin resistance and hyperinsulinaemia, which in turn lead to the development of diabetes, hypertension, atherosclerosis and coronary heart disease. Serum markers of inflammation are being increasingly recognized as predictors of atherosclerosis and cardiovascular risk, and chronic low-grade inflammation has been recently proposed to play a role in the pathogenesis of metabolic syndrome and type 2 diabetes mellitus. Therefore, the aim of the present study is to evaluate the effects of commonly used non-pharmacologic (diet and lifestyle change) and pharmacologic (oral contraceptives, metformin, anti-androgens) treatment strategies on classical and surrogate cardiovascular risk markers in women with PCOS. The study hypothesis is that some of the commonly used therapies of women with PCOS may have more favorable effects on classical and surrogate markers of cardiovascular risk then others or some of them may even confer a higher risk of cardiovascular events


Options:
A: Arm Label: Metformin; Type: EXPERIMENTAL; Interventions: Drug: Metformin, Behavioral: Lifestyle Intervention | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Behavioral: Lifestyle Intervention | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Metformin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BEHAVIORAL; Name: Lifestyle Intervention; Assigned to Arm(s): Metformin, Placebo
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Desorelle | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin, Drug: Desorelle | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): 1, 3 | Intervention Type: DRUG; Name: Desorelle; Assigned to Arm(s): 2, 3
C: Arm Label: Metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: oral metformin | Arm Label: Oral contraceptive; Type: ACTIVE_COMPARATOR; Interventions: Drug: oral contraceptive | Intervention Type: DRUG; Name: oral metformin; Assigned to Arm(s): Metformin | Intervention Type: DRUG; Name: oral contraceptive; Assigned to Arm(s): Oral contraceptive
D: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: metformin | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of the Sugar Sucrose on Bodyweight and Energy Intake Over 28 Days in Obese Women
Brief Summary: This study partially replicates two previous studies with normal weight women, and overweight women. Both found that women could compensate for sucrose added to the diet in carbonated soft drinks (4 x250ml total1800 kJ per day) when it was given blind over a period of 4 weeks. The hypothesis is that this applies also to obese women, who will not gain weight, increase overall energy intake in the diet, or eat differently whilst consuming sucrose. 42 participants shall be randomly assigned to either be given carbonated drinks that contain sucrose, or drinks that are artificially sweetened.


Options:
A: Arm Label: Sucrose; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Sucrose | Arm Label: Aspartame; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Aspartame | Intervention Type: DIETARY_SUPPLEMENT; Name: Sucrose; Assigned to Arm(s): Sucrose | Intervention Type: DIETARY_SUPPLEMENT; Name: Aspartame; Assigned to Arm(s): Aspartame
B: Intervention Type: BEHAVIORAL; Name: diet, sodium-restricted; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: diet, fat-restricted; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: exercise; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: diet, reducing; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: alcohol drinking; Assigned to Arm(s): N/A
C: Arm Label: Sugar-sweetened soft drink; Type: EXPERIMENTAL; Interventions: Other: Sugar-sweetened soft drink | Arm Label: Aspartame-sweetened soft drink; Type: EXPERIMENTAL; Interventions: Other: Aspartame-sweetened soft drink | Arm Label: Semi-skimmed milk; Type: ACTIVE_COMPARATOR; Interventions: Other: Semi-skimmed milk | Arm Label: Water; Type: PLACEBO_COMPARATOR; Interventions: Other: Water | Intervention Type: OTHER; Name: Sugar-sweetened soft drink; Assigned to Arm(s): Sugar-sweetened soft drink | Intervention Type: OTHER; Name: Aspartame-sweetened soft drink; Assigned to Arm(s): Aspartame-sweetened soft drink | Intervention Type: OTHER; Name: Semi-skimmed milk; Assigned to Arm(s): Semi-skimmed milk | Intervention Type: OTHER; Name: Water; Assigned to Arm(s): Water
D: Arm Label: Crispbread; Type: EXPERIMENTAL; Interventions: Behavioral: Crispbread | Arm Label: Liquid meal replacement; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Crispbread | Intervention Type: BEHAVIORAL; Name: Crispbread; Assigned to Arm(s): Crispbread, Liquid meal replacement

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of the Sugar Sucrose on Bodyweight and Energy Intake Over 28 Days in Obese Women
Brief Summary: This study partially replicates two previous studies with normal weight women, and overweight women. Both found that women could compensate for sucrose added to the diet in carbonated soft drinks (4 x250ml total1800 kJ per day) when it was given blind over a period of 4 weeks. The hypothesis is that this applies also to obese women, who will not gain weight, increase overall energy intake in the diet, or eat differently whilst consuming sucrose. 42 participants shall be randomly assigned to either be given carbonated drinks that contain sucrose, or drinks that are artificially sweetened.


Options:
A: Intervention Type: BEHAVIORAL; Name: A lifestyle educational program; Assigned to Arm(s): N/A
B: Intervention Type: BEHAVIORAL; Name: Promotion of a healthy diet and physical activity; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Avoidance of Alcohol, Drugs, and Tobacco; Assigned to Arm(s): N/A
C: Arm Label: Sucrose; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Sucrose | Arm Label: Aspartame; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Aspartame | Intervention Type: DIETARY_SUPPLEMENT; Name: Sucrose; Assigned to Arm(s): Sucrose | Intervention Type: DIETARY_SUPPLEMENT; Name: Aspartame; Assigned to Arm(s): Aspartame
D: Arm Label: No calorie beverages; Type: EXPERIMENTAL; Interventions: Behavioral: 2 no calorie beverages per day | Arm Label: Water; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 2 water beverages per day | Intervention Type: BEHAVIORAL; Name: 2 no calorie beverages per day; Assigned to Arm(s): No calorie beverages | Intervention Type: BEHAVIORAL; Name: 2 water beverages per day; Assigned to Arm(s): Water

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Discontinuing NSAIDs in Veterans With Knee Osteoarthritis
Brief Summary: Knee osteoarthritis (OA) is now recognized as a major health problem. It is the number one cause of lower extremity disability and has significant deleterious effects on quality of life. While there are numerous therapies available for knee OA, most have limited efficacy. Of particular concern, is the widespread use of nonsteroidal anti-inflammatory drugs (NSAIDs) for this disorder. Veterans, as a group, are at high risk for both gastrointestinal and cardiovascular NSAID-induced complications. In this study the investigators propose to examine whether replacing NSAIDs with cognitive behavioral therapy delivered by telephone is an effective strategy for Veterans with knee OA. Telephone-administered therapy is particularly appealing since Veterans with knee OA are more likely to have limited mobility. If successful, this program may result in significant cost-savings for both Veterans (decreased co-pays and transportation costs) and the VA (decreased hospitalizations due to NSAID induced toxicity).


Options:
A: Arm Label: web page; Type: ACTIVE_COMPARATOR; Interventions: Other: Webpage | Arm Label: Webpage and situational feedback; Type: EXPERIMENTAL; Interventions: Other: Webpage and situation feedback | Intervention Type: OTHER; Name: Webpage; Assigned to Arm(s): web page | Intervention Type: OTHER; Name: Webpage and situation feedback; Assigned to Arm(s): Webpage and situational feedback
B: Arm Label: relaxation; Type: EXPERIMENTAL; Interventions: Behavioral: Relaxation exercise | Arm Label: Usual care waiting list; Type: ACTIVE_COMPARATOR; Interventions: Other: ususal care | Intervention Type: BEHAVIORAL; Name: Relaxation exercise; Assigned to Arm(s): relaxation | Intervention Type: OTHER; Name: ususal care; Assigned to Arm(s): Usual care waiting list
C: Arm Label: Cognitive behavioral psychotherapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive behavioral psychotherapy | Arm Label: Waiting list; Type: OTHER; Interventions: Other: Waiting list | Intervention Type: BEHAVIORAL; Name: Cognitive behavioral psychotherapy; Assigned to Arm(s): Cognitive behavioral psychotherapy | Intervention Type: OTHER; Name: Waiting list; Assigned to Arm(s): Waiting list
D: Arm Label: Active Treatment; Type: EXPERIMENTAL; Interventions: Drug: Meloxicam 15 mg po QD | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy | Intervention Type: DRUG; Name: Meloxicam 15 mg po QD; Assigned to Arm(s): Active Treatment | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of the Hopeful Outdoor Parkinson Exercise (HOPE) Program on Improving Balance, Gait and Functional Performance in Parkinsonian Non-fallers and Single Fallers - a Randomized Controlled Trial With 12-month Follow-up
Brief Summary: To determine whether the 8-week Hopeful Outdoor Parkinson's Exercise (HOPE) Program would be effective in improving balance performance, physical functions, gait parameter, balance confidence, health-related quality-of-life, disease-specific motor performance and fall-related outcomes in Parkinson's disease (PD) non-fallers and single fallers.


Options:
A: Arm Label: Tai Chi; Type: EXPERIMENTAL; Interventions: Behavioral: Tai Chi | Arm Label: B. Strength training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Strength training | Arm Label: C. Low-Impact; Type: OTHER; Interventions: Behavioral: Low-Impact Exercise Control | Intervention Type: BEHAVIORAL; Name: Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Strength training; Assigned to Arm(s): B. Strength training | Intervention Type: BEHAVIORAL; Name: Low-Impact Exercise Control; Assigned to Arm(s): C. Low-Impact
B: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Other: interactive video game-based exercise, Other: no intervention | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Other: interactive video game-based exercise, Other: no intervention | Intervention Type: OTHER; Name: interactive video game-based exercise; Assigned to Arm(s): Group A, Group B | Intervention Type: OTHER; Name: no intervention; Assigned to Arm(s): Group A, Group B
C: Arm Label: IPX066; Type: EXPERIMENTAL; Interventions: Drug: IPX066, Drug: IR CD-LD | Arm Label: IR CD-LD; Type: ACTIVE_COMPARATOR; Interventions: Drug: IPX066, Drug: IR CD-LD | Intervention Type: DRUG; Name: IPX066; Assigned to Arm(s): IPX066, IR CD-LD | Intervention Type: DRUG; Name: IR CD-LD; Assigned to Arm(s): IPX066, IR CD-LD
D: Arm Label: EXPERIMENTAL; Type: EXPERIMENTAL; Interventions: Behavioral: an 8-week blended indoor-outdoor exercise program | Arm Label: CONTROL; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: an 8-week upper limb and hand exercise program | Intervention Type: BEHAVIORAL; Name: an 8-week blended indoor-outdoor exercise program; Assigned to Arm(s): EXPERIMENTAL | Intervention Type: BEHAVIORAL; Name: an 8-week upper limb and hand exercise program; Assigned to Arm(s): CONTROL

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Vision Restoration Training in Glaucoma - A Double-blind, Randomized, Placebo-controlled Clinical Trial
Brief Summary: Importance: Visual field loss after retinal damage in glaucoma is considered irreversible and methods are needed to achieve vision restoration. Behavioral vision restoration training (VRT), shown to improve visual fields in hemianopia and optic nerve damage, might comprise such a method.

Objective: To determine if behaviorally activating areas of residual visual (ARV) using VRT by daily one hour training for 3 months improves detection performance in perimetry compared to a vision discrimination task in the intact visual field sector.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Problem Solving Treatment | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control | Intervention Type: BEHAVIORAL; Name: Problem Solving Treatment; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): 2
B: Arm Label: Ranibizumab 0.3 mg; Type: EXPERIMENTAL; Interventions: Drug: Ranibizumab | Arm Label: Ranibizumab 0.5 mg; Type: EXPERIMENTAL; Interventions: Drug: Ranibizumab | Arm Label: Sham injection/ranibizumab 0.5 mg; Type: SHAM_COMPARATOR; Interventions: Drug: Sham injection | Intervention Type: DRUG; Name: Ranibizumab; Assigned to Arm(s): Ranibizumab 0.3 mg, Ranibizumab 0.5 mg | Intervention Type: DRUG; Name: Sham injection; Assigned to Arm(s): Sham injection/ranibizumab 0.5 mg
C: Arm Label: Visual Reconstitution Therapy; Type: EXPERIMENTAL; Interventions: Other: Visual Reconstitutions Therapy | Arm Label: Saccadic Eye Movement Training; Type: ACTIVE_COMPARATOR; Interventions: Other: Saccadic Eye Movement Training | Intervention Type: OTHER; Name: Visual Reconstitutions Therapy; Assigned to Arm(s): Visual Reconstitution Therapy | Intervention Type: OTHER; Name: Saccadic Eye Movement Training; Assigned to Arm(s): Saccadic Eye Movement Training
D: Arm Label: vision restoration training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: vision restoration training | Arm Label: Discrimination training; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Discrimination Training | Intervention Type: BEHAVIORAL; Name: vision restoration training; Assigned to Arm(s): vision restoration training | Intervention Type: BEHAVIORAL; Name: Discrimination Training; Assigned to Arm(s): Discrimination training

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Aerobic Training in Patients With Cirrhosis
Brief Summary: Cirrhosis is associated with a reduction in muscle mass and exercise capacity. This has an impact or morbidity and mortality. Regular aerobic exercise training is a proven effective therapy to improve exercise capacity in healthy and clinical populations. the effect of this training has not yet been evaluated in cirrhosis. The safety of this intervention also requires further study. Using a randomized controlled design, the investigators aim to conduct a pilot study evaluating the safety and efficacy of eight weeks of aerobic exercise training on aerobic capacity.


Options:
A: Arm Label: 1; Type: N/A; Interventions: N/A | Arm Label: 2; Type: N/A; Interventions: N/A
B: Arm Label: Aerobic exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Aerobic exercise | Arm Label: Usual care group; Type: PLACEBO_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: BEHAVIORAL; Name: Aerobic exercise; Assigned to Arm(s): Aerobic exercise | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual care group
C: Arm Label: Exercise, relaxation; Type: ACTIVE_COMPARATOR; Interventions: Other: Exercise + relaxation | Arm Label: Relaxation; Type: OTHER; Interventions: Other: Relaxation | Intervention Type: OTHER; Name: Exercise + relaxation; Assigned to Arm(s): Exercise, relaxation | Intervention Type: OTHER; Name: Relaxation; Assigned to Arm(s): Relaxation
D: Arm Label: Home based aerobic exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Home based Aerobic exercise training | Arm Label: Usual Care group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home based Aerobic exercise training; Assigned to Arm(s): Home based aerobic exercise

Answer: B